Evidence map›Paper›PMID 32124185›Full record

ArticleJournal of neuro-oncology2020

Clinical presentation of young people (10-24 years old) with brain tumors: results from the international MOBI-Kids study.

Angela Zumel-Marne, Michael Kundi, Gemma Castaño-Vinyals, Juan Alguacil, Eleni Th Petridou, Marios K Georgakis, Maria Morales-Suárez-Varela, Siegal Sadetzki, Sara Piro, Rajini Nagrani and 26 more

Open access · hybridAbstract readMulticenter Study
In one paragraph

Article in Journal of neuro-oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 28 citations in OpenAlex.

  1. Cancer Effects of Low to Moderate Doses of Ionizing Radiation in Young People with Cancer-Predisposing Conditions: A Systematic Review.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2022
    Pooled it
  2. Bridging pediatric and adult neuro-oncology: Insights into adolescents and young adults (AYA) central nervous system tumors.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

36 authors at 20 institutions in 14 countries.

Angela Zumel-MarneISGlobal, Barcelona, Spain.
Michael KundiCenter for Public Health, Department of Environmental Health, Medical University Vienna, Vienna, Austria.
Gemma Castaño-VinyalsISGlobal, Barcelona, Spain.
Juan AlguacilCiber Epidemiología y Salud Pública (CIBERESP), Madrid, Spain. alguacil@dbasp.uhu.es.
Eleni Th PetridouDepartment of Hygiene, Epidemiology and Medical Statistics, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
Marios K GeorgakisDepartment of Hygiene, Epidemiology and Medical Statistics, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
Maria Morales-Suárez-VarelaCiber Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
Siegal SadetzkiPublic Health Services, Ministry of Health, Tel Aviv, Israel.
Sara PiroEnvironmental and Occupational Epidemiology Branch, Cancer Risk Factors and Lifestyle Epidemiology Unit, Institute for Cancer Research Prevention and Clinical Network-ISPRO, Florence, Italy.
Rajini NagraniCentre for Cancer Epidemiology, Tata Memorial Centre, Mumbai, India.
Graziella FilippiniScientific Director's Office, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.
Hans-Peter HutterCenter for Public Health, Department of Environmental Health, Medical University Vienna, Vienna, Austria.
Rajesh DikshitCentre for Cancer Epidemiology, Tata Memorial Centre, Mumbai, India.
Adelheid WoehrerInstitute of Neurology, Medical University Vienna, Vienna, Austria.
Milena MauleUnit of Cancer Epidemiology, Department of Medical Sciences, University of Turin, Turin, Italy.
Tobias WeinmannInstitute and Clinic for Occupational, Social and Environmental Medicine, University Hospital, LMU Munich, Munich, Germany.
Daniel KrewskiSchool of Epidemiology and Public Health, University of Ottawa, Ottawa, Canada.
Andrea T MannetjeCentre for Public Health Research, Massey University, Wellington, New Zealand.
Franco MomoliSchool of Epidemiology and Public Health, University of Ottawa, Ottawa, Canada.
Brigitte LacourFrench National Registry of Childhood Solid Tumors, CHU, Nancy, France.
Stefano MattioliDepartment of Medical and Surgical Sciences (DIMEC), University of Bologna, Bologna, Italy.
John J SpinelliPopulation Oncology, BC Cancer, Vancouver, Canada.
Paul RitvoSchool of Kinesiology and Health Science and Department of Psychology, York University, Toronto, Canada.
Thomas RemenFrench National Registry of Childhood Solid Tumors, CHU, Nancy, France.
Noriko KojimaharaDepartment of Public Health, Tokyo Women's Medical University, Tokyo, Japan.
Amanda EngCentre for Public Health Research, Massey University, Wellington, New Zealand.
Angela ThurstonCentre for Public Health Research, Massey University, Wellington, New Zealand.
Hyungryul LimDepartment of Preventive Medicine, Dankook University College of Medicine, Cheonan, South Korea.
Mina HaDepartment of Preventive Medicine, Dankook University College of Medicine, Cheonan, South Korea.
Naohito YamaguchiDepartment of Public Health, Tokyo Women's Medical University, Tokyo, Japan.
Charmaine MohippChildren's Hospital of Eastern Ontario, Ottawa, ON, Canada.
Evdoxia BoukaDepartment of Hygiene, Epidemiology and Medical Statistics, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
Chelsea EastmanISGlobal, Barcelona, Spain.
Roel VermeulenDivision Environmental Epidemiology, Institute for Risk Assessment Sciences, Utrecht University, Utrecht, The Netherlands.
Hans KromhoutDivision Environmental Epidemiology, Institute for Risk Assessment Sciences, Utrecht University, Utrecht, The Netherlands.
Elisabeth CardisISGlobal, Barcelona, Spain.
Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública · ESMassey University · NZBarcelona Institute for Global Health · ESDankook University · KRMedical University of Vienna · ATNational and Kapodistrian University of Athens · GRTokyo Women's Medical University · JPUniversity of Ottawa · CAUtrecht University · NLAdvanced Centre for Treatment, Research and Education in Cancer · INChildren's Hospital of Eastern Ontario · CAFondazione IRCCS Istituto Neurologico Carlo Besta · ITKarolinska Institutet · SELaboratoire d’immunologie intégrative du cancer · FRLMU Klinikum · DETata Memorial Hospital · INTel Aviv University · ILUniversitat Pompeu Fabra · ESUniversity of Bologna · ITUniversity of British Columbia · CA

Funding

European Community 226873European Community 603794
6 · The paper itself

Abstract

introductionWe used data from MOBI-Kids, a 14-country international collaborative case-control study of brain tumors (BTs), to study clinical characteristics of the tumors in older children (10 years or older), adolescents and young adults (up to the age of 24).

methodsInformation from clinical records was obtained for 899 BT cases, including signs and symptoms, symptom onset, diagnosis date, tumor type and location.

resultsOverall, 64% of all tumors were low-grade, 76% were neuroepithelial tumors and 62% gliomas. There were more males than females among neuroepithelial and embryonal tumor cases, but more females with meningeal tumors. The most frequent locations were cerebellum (22%) and frontal (16%) lobe. The most frequent symptom was headaches (60%), overall, as well as for gliomas, embryonal and 'non-neuroepithelial' tumors; it was convulsions/seizures for neuroepithelial tumors other than glioma, and visual signs and symptoms for meningiomas. A cluster analysis showed that headaches and nausea/vomiting was the only combination of symptoms that exceeded a cutoff of 50%, with a joint occurrence of 67%. Overall, the median time from first symptom to diagnosis was 1.42 months (IQR 0.53-4.80); it exceeded 1 year in 12% of cases, though no particular symptom was associated with exceptionally long or short delays.

conclusionsThis is the largest clinical epidemiology study of BT in young people conducted so far. Many signs and symptoms were identified, dominated by headaches and nausea/vomiting. Diagnosis was generally rapid but in 12% diagnostic delay exceeded 1 year with none of the symptoms been associated with a distinctly long time until diagnosis.

Indexed as

AdolescentAdultBrain NeoplasmsCase-Control StudiesChildDelayed DiagnosisFemaleFollow-Up StudiesGlobal HealthHumansMalePrevalencePrognosisSurvival RateYoung AdultBrain tumorCentral nervous system tumorClinical characteristicDiagnosisSymptom

Identifiers

PMID32124185
PMCPMC7136306
OpenAlexW3010028553

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.